Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study.

Area of Science:

• Pediatric Oncology
• Hematology
• Pathology

Background:

• Mediastinal non-lymphoblastic lymphoma (NLBL) is a rare subtype of pediatric non-Hodgkin's lymphoma (NHL), representing approximately 5% of cases.
• Patients often present with symptoms related to a large mediastinal mass, frequently involving superior vena cava syndrome.

Purpose of the Study:

• To review the clinicopathologic features and treatment outcomes of pediatric patients diagnosed with mediastinal NLBL.
• To identify distinctive characteristics of this disease in children to inform treatment protocol design.

Main Methods:

• Retrospective review of medical records for 25 pediatric patients with mediastinal NLBL.
• Analysis of presenting symptoms, disease localization, histopathologic classification (Rappaport and Working Formulation), treatment regimens, and patient outcomes.

Main Results:

• The median age of patients was 13.5 years, with a slight female predominance (15 females, 10 males).
• Most cases were classified as diffuse histiocytic type (Rappaport) or large-cell immunoblastic type (Working Formulation).
• Treatment involved multiagent chemotherapy (23 patients) and mediastinal radiation (20 patients), leading to a 92% complete remission (CR) rate, with 74% remaining disease-free for a median of 43 months.

Conclusions:

• Pediatric mediastinal NLBL exhibits distinct clinicopathologic features.
• Current treatment approaches, including chemotherapy and radiation, yield high CR rates and durable disease-free survival.
• Special consideration in treatment protocol design is warranted for this specific pediatric malignancy.